Evidence map›Paper›PMID 32273868›Full record

ReviewFrontiers in psychology2020

Multidimensional Approach to Frailty.

Marta Wleklik, Izabella Uchmanowicz, Ewa A Jankowska, Cristiana Vitale, Magdalena Lisiak, Marcin Drozd, Piotr Pobrotyn, Michał Tkaczyszyn, Christopher Lee

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in psychology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Marta WleklikFaculty of Health Sciences, Wrocław Medical University, Wrocław, Poland.
Izabella UchmanowiczFaculty of Health Sciences, Wrocław Medical University, Wrocław, Poland.
Ewa A JankowskaCentre for Heart Diseases, Faculty of Health Sciences, Wrocław Medical University, Wrocław, Poland.
Cristiana VitaleCentre for Clinical and Basic Research, IRCCS San Raffaele Pisana, Rome, Italy.
Magdalena LisiakFaculty of Health Sciences, Wrocław Medical University, Wrocław, Poland.
Marcin DrozdCentre for Heart Diseases, Faculty of Health Sciences, Wrocław Medical University, Wrocław, Poland.
Piotr PobrotynClinical University Hospital, Wrocław, Poland.
Michał TkaczyszynCentre for Heart Diseases, Faculty of Health Sciences, Wrocław Medical University, Wrocław, Poland.
Christopher LeeWilliam F. Conell School of Nursing, Boston College, Newton, MA, United States.
Wroclaw Medical University · PLBoston College · USIstituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concept of frailty syndrome (FS) was first described in the scientific literature three decades ago. For a very long time, we understood it as a geriatric problem, recently becoming one of the dominant concepts in cardiology. It identifies symptoms of FS in one in 10 elderly people. It is estimated that in Europe, 17% of elderly people have FS. The changes in FS resemble and often overlap with changes associated with the physiological aging process of the body. Although there are numerous scientific reports confirming that FS is age correlated, it is not an unavoidable part of the aging process and does not apply only to the elderly. FS is a reversible clinical condition. To maximize benefits of frailty-reversing activities for patient with frailty, identification of its determinants appears to be fundamental. Many of the determinants of the FS have already been known: reduction in physical activity, malnutrition, sarcopenia, polypharmacy, depressive symptom, cognitive disorders, and lack of social support. This review shows that insight into FS determinants is the starting point for building both the comprehensive definition of FS and the adoption of the assessment method of FS, and then successful clinical management.

Indexed as

cardiologydeterminantsdisabilityelderlyfrailty syndromemulti-morbidity

Identifiers

PMID32273868
PMCPMC7115252
OpenAlexW3013893251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.